Gestagens in the therapy of endometriosis
article
OA: closed
CC0
⤵ 3 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper reviews the use of gestagens as a therapeutic option for endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (3)
- Pharmacological Management of Endometriosis-related Pain: The Expert Opinion 2021
- Hormone therapy for patients with endometriosis: status update on the problem (literature review) 2020
- Advisory Board Resolution on the subject: 'Possibilities of personalized hormone-based therapies for endometriosis using dydrogesterone / Approval of the protocol of an Observational Open-Label Multicenter Study of Real Clinical Practice to Evaluate the Effects of Hormonal therapy with Oral Dydrogesterone for Treatment of Confirmed Endometriosis (the ORCHIDEA study)' 2018
Cited by (3)
- Pharmacological Management of Endometriosis-related Pain: The Expert Opinion 2021
- Hormone therapy for patients with endometriosis: status update on the problem (literature review) 2020
- Advisory Board Resolution on the subject: 'Possibilities of personalized hormone-based therapies for endometriosis using dydrogesterone / Approval of the protocol of an Observational Open-Label Multicenter Study of Real Clinical Practice to Evaluate the Effects of Hormonal therapy with Oral Dydrogesterone for Treatment of Confirmed Endometriosis (the ORCHIDEA study)' 2018
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-06-13T06:42:57.164913+00:00
License: CC0
· commercial use OK